NORTHERN TRUST CORP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$143,055
-42.4%
99,344
-0.4%
0.00%
Q2 2023$248,286
-25.6%
99,713
-19.9%
0.00%
Q1 2023$333,792
-47.8%
124,549
+5.8%
0.00%
Q4 2022$639,421
-45.0%
117,757
+26.7%
0.00%
Q3 2022$1,162,000
+155.9%
92,975
+1.2%
0.00%
Q2 2022$454,000
-84.7%
91,891
-76.5%
0.00%
-100.0%
Q1 2022$2,968,000
-28.6%
390,586
-4.0%
0.00%0.0%
Q4 2021$4,155,000
-23.7%
406,967
+0.3%
0.00%0.0%
Q3 2021$5,448,000
-40.9%
405,911
-3.4%
0.00%
-50.0%
Q2 2021$9,222,000
+2.0%
420,372
+11.9%
0.00%0.0%
Q1 2021$9,038,000
+25.6%
375,687
-6.1%
0.00%
+100.0%
Q4 2020$7,196,000
+49.8%
400,013
-3.8%
0.00%0.0%
Q3 2020$4,804,000
-54.1%
415,943
-3.7%
0.00%
-50.0%
Q2 2020$10,477,000
+127.2%
431,805
+3.2%
0.00%
+100.0%
Q1 2020$4,611,000
-58.4%
418,494
-0.3%
0.00%
-50.0%
Q4 2019$11,097,000
+20.6%
419,863
+3.9%
0.00%0.0%
Q3 2019$9,203,000
-0.8%
404,010
+33.6%
0.00%0.0%
Q2 2019$9,273,000
+92.5%
302,452
+4.2%
0.00%
+100.0%
Q1 2019$4,817,000
-10.7%
290,152
+3.0%
0.00%
-50.0%
Q4 2018$5,393,000
-60.7%
281,680
+7.4%
0.00%
-33.3%
Q3 2018$13,715,000
+30.1%
262,320
+8.2%
0.00%0.0%
Q2 2018$10,538,000
+81.8%
242,495
+55.0%
0.00%
+50.0%
Q1 2018$5,796,000
+250.6%
156,437
+87.8%
0.00%
Q4 2017$1,653,000
+2.1%
83,288
+28.0%
0.00%
Q3 2017$1,619,00065,0490.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 98,482$1,631,0000.60%
Opus Point Partners Management, LLC 20,844$346,0000.47%
HHLR ADVISORS, LTD. 949,431$15,761,0000.44%
Rhenman & Partners Asset Management AB 212,169$3,522,0000.41%
Virtus ETF Advisers LLC 8,654$144,0000.31%
BB BIOTECH AG 671,925$11,154,0000.28%
RA Capital Management 363,051$6,027,0000.26%
BDO Wealth Advisors, LLC 35,234$585,0000.17%
Birchview Capital, LP 15,000$249,0000.16%
SECOR Capital Advisors, LP 37,205$618,0000.13%
View complete list of G1 THERAPEUTICS INC shareholders